Abstract

Antibody production by a protease-deficient strain of methylotrophic yeast, Ogataea minuta

Highlights

  • At present the expression system of mammalian cells such as CHO has been adopted as the conventional method to produce antibody for pharmaceuticals

  • The 4th Recombinant Protein Production Meeting: a comparative view on host physiology The organisers would like to thank Novozymes Delta Ltd who generously supported the meeting. Meeting abstracts – A single PDF containing all abstracts in this supplement is available here http://www.biomedcentral.com/content/pdf/1475-2859-5-S1-info.pdf

  • When human antibody genes were introduced in the methylotrophic yeast O. minuta to produce an antibody, the heavy chain of the antibody was partially degraded

Read more

Summary

Introduction

At present the expression system of mammalian cells such as CHO has been adopted as the conventional method to produce antibody for pharmaceuticals. Antibody production by a protease-deficient strain of methylotrophic yeast, Ogataea minuta Kousuke Kuroda*1, Yoshinori Kitagawa[1], Kazuo Kobayashi[1], Haruhiko Tsumura[1], Toshihiro Komeda[2], Yasunori Chiba[3] and Yoshihumi Jigami[3] Address: 1Kirin Brewery Co., Ltd., CMC R&D Lab, Gunma, Japan, 2Kirin Brewery Co., Ltd., Central Lab for Frontier Technology, Kanagawa, Japan and 3National Institute Advanced Industrial Science and Technology (AIST), Ibaragi, Japan * Corresponding author from The 4th Recombinant Protein Production Meeting: a comparative view on host physiology Barcelona, Spain.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.